Researchers at Weill Cornell Medicine have developed a pre-clinical model of the leading cause of central vision loss in older individuals, dry age-related macular degeneration, and used it to identify new treatment modalities and drug targets.
Globally, by the end of this century low-income cattle farmers in poor countries may face financial loss between $15 to $40 billion annually, due to looming climate change.
White blood cells called neutrophils have an unappreciated role in eradicating solid tumors, according to a surprise discovery from a team led by Weill Cornell Medicine scientists.
White-tailed deer – the most abundant large mammal in North America – are harboring SARS-CoV-2 variants that once widely circulated but are no longer found in humans.
A growing percentage of U.S. adults, even those who trust science, said harassing or threatening public health officials over COVID-19 business closures was justified, according to a new study of public opinion surveys conducted during two phases of the pandemic.
A study suggests boosting “naturally-produced” antibodies in mothers may enhance infants’ immunity against bacterial pathogens that cause infectious gastrointestinal diseases.
A Cornell-led collaboration used machine learning to pinpoint the most accurate means, and timelines, for anticipating the advancement of Alzheimer’s disease.
Employers who use technological advancement to reshape workers’ jobs can help improve patient care while improving the work experience of frontline health care workers, Associate Professor Adam Seth Litwin argues in a peer-reviewed commentary.
New research in biomechanics measures the impact of head-first, hand-first and feet-first diving and the likelihood of injury at different diving heights.
Robert J. “Bob” Appel ’53, a vice chair of Weill Cornell Medicine’s Board of Fellows, Cornell trustee emeritus and presidential councillor, died Nov. 19 in New York, at age 91.